Download pdf version


INSIDE
RINDERPEST
Rinderpest surveillance in Afghanistan and Pakistan
FOOT-AND-MOUTH DISEASE
Ministerial meeting on FMD, FAO headquarters, Rome, 6 November 2001 - Global action against FMD proposed

FMD crises in the United Kingdom and their reflection on Europe
CONTAGIOUS BOVINE PLEUROPNEUMONIA IN SOUTHERN AFRICA
Conceptualizing the Xhosa cattle-killing episode of 1856/7
ANIMAL DISEASE INFORMATION SYSTEMS
TADinfo

Animal health information system in India

Regional networks
COMMUNICATIONS
Complications arising from the use of recombinant vaccinia vaccines in immunosuppressed people
NEWS
New head of the Infectious Diseases Group-EMPRES

New Web site on FMD

Introduction of new staff
CONTRIBUTIONS FROM FAO REFERENCE LABORATORIES AND COLLABORATING CENTRES
Reports from FAO/OIE World Reference Laboratory for FMD, Pirbright, UK
NEWS@RADISCON
RADISCON phase two project presented to donors

NEW HEAD OF THE INFECTIOUS DISEASES GROUP-EMPRES

The FAO Director-General has appointed Dr Juan Lubroth, a United States citizen, as Senior Officer, Infectious Diseases Group-EMPRES. He succeeds Mark Rweyemamu, and will formally assume his duties in February 2002.

Juan comes to FAO by way of the United States Department of Agriculture's Plum Island Animal Disease Center, where he worked as Head of the Reagents and Vaccine Services Unit, Foreign Animal Disease Diagnostic Laboratory.


Juan Lubroth: new head of IDG-EMPRES

MINISTERIAL MEETING ON FOOT-AND-MOUTH DISEASE - GLOBAL ACTION AGAINST FMD PROPOSED

FAO member countries and organizations that participated in the `'Ministerial Meeting on the Experiences of FMD'', held during the thirty-first session of the FAO Conference, have all lent their support to the call for a global partnership to fight the devastating effects of FMD in the world. During the Ministerial meeting, it was observed that FMD goes beyond a vet-erinary issue and that its negative con-sequences are not limited to the agri-culture sector alone, but also encompass the livelihoods of rural people, as demonstrated re-cently by the FMD outbreak in Europe.


FAO Plenary Hall during the Conference

COMPLICATIONS ARISING FROM THE USE OF RECOMBINANT VACCINIA VACCINES IN IMMUNOSUPPRESSED PEOPLE

Some concern about the use of recombinant vaccinia vaccines in immunosuppressed people has been brought to the fore again following the contamination of a woman from Ohio, United States, with the recombinant vaccinia-rabies glycoprotein virus.